Early Toll-like receptor 4 inhibition improves immune dysfunction in the hippocampus after hypoxic-ischemic brain damage
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 19 (1) , 142-151
Abstract
Background: Toll-like receptor 4 (TLR4) is implicated in neonatal hypoxic-ischemic brain damage (HIBD), but the underlying mechanism is unclear.Keywords
This publication has 51 references indexed in Scilit:
- Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic‐ischemic brain injuryThe FASEB Journal, 2013
- TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and ReperfusionMediators of Inflammation, 2013
- Changes of Inflammatory Cytokines and Neurotrophins Emphasized Their Roles in Hypoxic–Ischemic Brain DamageInternational Journal of Neuroscience, 2012
- Long Lasting Local and Systemic Inflammation after Cerebral Hypoxic ischemia in Newborn MicePLOS ONE, 2012
- Neonatal Sepsis and Neutrophil InsufficienciesInternational Reviews of Immunology, 2010
- Toll‐like receptors in central nervous system glial inflammation and homeostasisJournal of Neuroscience Research, 2006
- Interleukin-6 and tumor necrosis factor-α levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic–ischemic encephalopathyThe Journal of Pediatrics, 2003
- Chemokine and Inflammatory Cell Response to Hypoxia-Ischemia in Immature RatsPediatric Research, 1999
- Microglia activation after neonatal hypoxic-ischemiaDevelopmental Brain Research, 1995
- The influence of immaturity on hypoxic‐ischemic brain damage in the ratAnnals of Neurology, 1981